294 related articles for article (PubMed ID: 22572106)
1. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
3. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.
Elias D; Delperro JR; Sideris L; Benhamou E; Pocard M; Baton O; Giovannini M; Lasser P
Ann Surg Oncol; 2004 May; 11(5):518-21. PubMed ID: 15123461
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
[TBL] [Abstract][Full Text] [Related]
5. Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
Zani S; Papalezova K; Stinnett S; Tyler D; Hsu D; Blazer DG
J Surg Oncol; 2013 Mar; 107(4):307-11. PubMed ID: 22811275
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
Klaver YL; Chua TC; de Hingh IH; Morris DL
J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
[TBL] [Abstract][Full Text] [Related]
7. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.
Pelz JO; Chua TC; Esquivel J; Stojadinovic A; Doerfer J; Morris DL; Maeder U; Germer CT; Kerscher AG
BMC Cancer; 2010 Dec; 10():689. PubMed ID: 21176206
[TBL] [Abstract][Full Text] [Related]
9. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
[TBL] [Abstract][Full Text] [Related]
11. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study.
Bloemendaal AL; Verwaal VJ; van Ruth S; Boot H; Zoetmulder FA
Eur J Surg Oncol; 2005 Dec; 31(10):1145-51. PubMed ID: 16084051
[TBL] [Abstract][Full Text] [Related]
12. Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL
Am J Surg; 2011 Feb; 201(2):149-56. PubMed ID: 20832051
[TBL] [Abstract][Full Text] [Related]
13. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.
Passot G; Vaudoyer D; Cotte E; You B; Isaac S; Noël Gilly F; Mohamed F; Glehen O
Ann Surg; 2012 Jul; 256(1):125-9. PubMed ID: 22580942
[TBL] [Abstract][Full Text] [Related]
14. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy.
Klaver YL; de Hingh IH; Boot H; Verwaal VJ
J Surg Oncol; 2011 Apr; 103(5):431-4. PubMed ID: 21400529
[TBL] [Abstract][Full Text] [Related]
15. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
[TBL] [Abstract][Full Text] [Related]
17. [Specific treatment situations in metastatic colorectal cancer].
Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
Verwaal VJ; van Tinteren H; Ruth SV; Zoetmulder FA
J Surg Oncol; 2004 Feb; 85(2):61-7. PubMed ID: 14755505
[TBL] [Abstract][Full Text] [Related]
19. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J
Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
[TBL] [Abstract][Full Text] [Related]
20. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
Verwaal VJ; van Tinteren H; van Ruth S; Zoetmulder FA
Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]